Home
Financials
SEC Filings
SEC Filings
Investor Contact

Media & Investor Relations:
Troy Wichterman 
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com

Transfer Agent

Broadridge Corporate Issuer Solutions, Inc. 
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com

Investor Alerts

Register here to receive email notifications with updates about our press releases, stock price, SEC filings and more.

SEC Filings

NASDAQBLFS
YearTrailing 12-MonthsCalendar Year 2024Calendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014Calendar Year 2013Calendar Year 2012Calendar Year 2011Calendar Year 2010Calendar Year 2009Calendar Year 2008Calendar Year 2007Calendar Year 2006Calendar Year 2005Calendar Year 2004Calendar Year 2003Calendar Year 2002Calendar Year 2001Calendar Year 2000Calendar Year 1999Calendar Year 1998Calendar Year 1997Calendar Year 1996Calendar Year 1995
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Proxy & Information StatementsOther
FormDescriptionDateFormat
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsNov 08, 2024Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in HTML.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in DOC file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in PDF file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in XLS file.
SC 13G/AAmendment to a previously filed SC 13GNov 01, 2024Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.
144Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stockSep 18, 2024Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in HTML.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in DOC file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in PDF file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in XLS file.
144Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stockAug 19, 2024Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in HTML.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in DOC file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in PDF file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in XLS file.
144Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stockMar 12, 2024Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in HTML.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in DOC file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in PDF file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in XLS file.
SC 13G/AAmendment to a previously filed SC 13GFeb 13, 2024Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsFeb 02, 2024Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in HTML.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in DOC file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in PDF file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in XLS file.
SC 13G/AAmendment to a previously filed SC 13GJan 24, 2024Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.
SC 13G/AAmendment to a previously filed SC 13GJan 23, 2024Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.

CONTACT

BioLife Solutions Inc.
3303 Monte Villa Parkway,
Suite 310, Bothell, WA 98021  USA

T +1.866.424.6543 or 425.402.1400
F +1.425.402.1433

NAVIGATION

SOLUTIONS

FURTHER INFORMATION

Investor Alerts

Investor Alerts
* Required Fields
Facebook Linkedin Youtube Twitter
Back to top

©Copyright 2024 | Design by The Unknown Creative